BeiGene Ltd.

NASDAQ: BGNE · Real-Time Price · USD
184.71
0.90 (0.49%)
At close: Dec 31, 2024, 10:00 PM

BeiGene Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-644.79M -881.71M -2B -1.41B
Depreciation & Amortization
171.76M 87.67M 66.28M 46.46M
Stock-Based Compensation
441.62M 367.62M 303.16M 240.71M
Other Working Capital
142.28M -62.77M -110.68M 438M
Other Non-Cash Items
21.96M -361.19M 3.31M -13.11M
Deferred Income Tax
25.98M 689K 2.06M -41.09M
Change in Working Capital
-157.17M -370.54M 132.39M -118.34M
Operating Cash Flow
-140.63M -1.16B -1.5B -1.3B
Capital Expenditures
-529.14M -596.26M -469.1M -314.85M
Cash Acquisitions
n/a n/a -1.4B 51.91M
Purchase of Investments
-19.01M -16.98M -17.4M -2.19B
Sales Maturities Of Investments
2.65M 673.24M 1.56B 3.15B
Other Investing Acitivies
-39.34M -15M 1.4B -51.91M
Investing Cash Flow
-548.35M 60M 1.08B 640.66M
Debt Repayment
145.08M 360.77M -65.94M 101.53M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
48.37M 55.71M 46.96M 92.76M
Financial Cash Flow
193.45M 416.48M -18.97M 3.64B
Net Cash Flow
-547.24M -689.05M -507.85M 2.99B
Free Cash Flow
-669.77M -1.75B -1.97B -1.61B